Ignite Creation Date:
2024-05-06 @ 9:41 AM
Last Modification Date:
2024-10-26 @ 12:17 PM
Study NCT ID:
NCT03040999
Status:
COMPLETED
Last Update Posted:
2024-02-26
First Post:
2017-02-01
Brief Title:
Study of Pembrolizumab MK-3475 or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma MK-3475-412KEYNOTE-412
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Organization Data
Organization:
Merck Sharp Dohme LLC
Class:
INDUSTRY
Study ID:
3475-412
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merck Sharp Dohme LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None